BindingDB logo
myBDB logout

BDBM160206 US9040663, 52

SMILES: CC(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H]1CCCNC(=O)CC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccc(cc2)C#N)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O)C(N)=O

InChI Key: InChIKey=OBKWMOSDTIUARN-GSAPFWBWSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 160206   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Melanocortin receptor 4


(Homo sapiens (Human))
BDBM160206
PNG
(US9040663, 52)
Show SMILES CC(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H]1CCCNC(=O)CC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccc(cc2)C#N)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O)C(N)=O
Show InChI InChI=1S/C51H69N19O9/c1-28(71)64-36(9-5-19-60-50(54)55)44(74)66-37-10-4-18-59-42(72)17-16-35(43(53)73)65-48(78)40(22-31-25-62-34-8-3-2-7-33(31)34)69-45(75)38(11-6-20-61-51(56)57)67-47(77)39(21-29-12-14-30(24-52)15-13-29)68-49(79)41(70-46(37)76)23-32-26-58-27-63-32/h2-3,7-8,12-15,25-27,35-41,62H,4-6,9-11,16-23H2,1H3,(H2,53,73)(H,58,63)(H,59,72)(H,64,71)(H,65,78)(H,66,74)(H,67,77)(H,68,79)(H,69,75)(H,70,76)(H4,54,55,60)(H4,56,57,61)/t35-,36+,37-,38-,39+,40-,41-/m0/s1
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
0.600 -13.1n/an/an/an/an/a7.537



AstraZeneca AB

US Patent


Assay Description
A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...


US Patent US9040663 (2015)


BindingDB Entry DOI: 10.7270/Q29885SK
More data for this
Ligand-Target Pair
Melanocyte-stimulating hormone receptor


(Homo sapiens (Human))
BDBM160206
PNG
(US9040663, 52)
Show SMILES CC(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H]1CCCNC(=O)CC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccc(cc2)C#N)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O)C(N)=O
Show InChI InChI=1S/C51H69N19O9/c1-28(71)64-36(9-5-19-60-50(54)55)44(74)66-37-10-4-18-59-42(72)17-16-35(43(53)73)65-48(78)40(22-31-25-62-34-8-3-2-7-33(31)34)69-45(75)38(11-6-20-61-51(56)57)67-47(77)39(21-29-12-14-30(24-52)15-13-29)68-49(79)41(70-46(37)76)23-32-26-58-27-63-32/h2-3,7-8,12-15,25-27,35-41,62H,4-6,9-11,16-23H2,1H3,(H2,53,73)(H,58,63)(H,59,72)(H,64,71)(H,65,78)(H,66,74)(H,67,77)(H,68,79)(H,69,75)(H,70,76)(H4,54,55,60)(H4,56,57,61)/t35-,36+,37-,38-,39+,40-,41-/m0/s1
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
6 -11.7n/an/an/an/an/a7.537



AstraZeneca AB

US Patent


Assay Description
A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...


US Patent US9040663 (2015)


BindingDB Entry DOI: 10.7270/Q29885SK
More data for this
Ligand-Target Pair